Study of Obeldesivir in Nonhospitalized Participants With COVID-19
Summary
- Eligibility
- for people ages 12-64 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Gilead Sciences
- Links
- Gilead Clinical Trials Website
- ID
- NCT05715528
- Phase
- Phase 3 COVID-19 Research Study
- Study Type
- Interventional
- Participants
- Expecting 1900 study participants
- Last Updated